Advanced search
2 files | 63.24 KB Add to list

Hoeveel profiteert de farma-industrie?

Frank Roels (UGent)
Author
Organization
Abstract
The secret deals by the minister of Health & Social security with big pharma are critizised by the media because they are profitable for the industry. I point to my communication at the SSIEM meeting in 2022 that lists high prizes of medicines, and the net profit of companies. 14 companies totalled around 150 billion net profit in 2021. I proposed that prize negociations should be lead by a consortium of all or many (European) governments, instead of by Belgium alone. This approach is included in the election program of the ministers party (Vooruit), but it is unclear who is blocking it.
Keywords
health insurance, expensive medicines, price negociation, Pfizer, Johnson & J, GSK, Abbvie, Sanofi, Gilead, Novartis, Roch, Merck, Novo Nordisk, Biogen, EliLilly, AstraZeneca, Vertex, Compulsory licencing

Downloads

  • Farmadeals lezersbrief Rosier.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 31.18 KB
  • NOVEL MEDICINES POSTER 27.pptx
    • data factsheet
    • |
    • open access
    • |
    • PowerPoint
    • |
    • 32.05 KB

Citation

Please use this url to cite or link to this publication:

MLA
Roels, Frank. “Hoeveel Profiteert de Farma-Industrie?” De Standaard, Mediahuis nv, 2024.
APA
Roels, F. (2024). Hoeveel profiteert de farma-industrie? De Standaard.
Chicago author-date
Roels, Frank. 2024. “Hoeveel Profiteert de Farma-Industrie?” De Standaard.
Chicago author-date (all authors)
Roels, Frank. 2024. “Hoeveel Profiteert de Farma-Industrie?” De Standaard.
Vancouver
1.
Roels F. Hoeveel profiteert de farma-industrie? De Standaard. 2024;
IEEE
[1]
F. Roels, “Hoeveel profiteert de farma-industrie?,” De Standaard, 2024.
@article{01HWNBHRTJSG0Z5XFBCRR7MRFN,
  abstract     = {{The secret deals by the minister of Health & Social security with big pharma are critizised by the media because they are profitable for the industry. I point to my communication at the SSIEM meeting in 2022 that lists high prizes of medicines, and the net profit of companies. 14 companies totalled around 150 billion net profit in 2021. I proposed that prize negociations should be lead by a consortium of all or many (European) governments, instead of by Belgium alone. This approach is included in the election program of the ministers party (Vooruit), but it is unclear who is blocking it.}},
  author       = {{Roels, Frank}},
  journal      = {{De Standaard}},
  keywords     = {{health insurance,expensive medicines,price negociation,Pfizer,Johnson & J,GSK,Abbvie,Sanofi,Gilead,Novartis,Roch,Merck,Novo Nordisk,Biogen,EliLilly,AstraZeneca,Vertex,Compulsory licencing}},
  language     = {{dut}},
  pages        = {{3}},
  publisher    = {{Mediahuis nv}},
  title        = {{Hoeveel profiteert de farma-industrie?}},
  year         = {{2024}},
}